Published in J Exp Med on December 07, 1998
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66
Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol (2001) 2.64
Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev (2008) 2.13
Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med (2000) 1.46
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J Clin Invest (2004) 1.39
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood (2008) 1.32
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. J Exp Med (2007) 1.30
Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. J Virol (2002) 1.22
Stimulation of hematopoiesis by the Fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice. Infect Immun (2003) 0.99
Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol (2014) 0.92
Dendritic cell-based vaccines: barriers and opportunities. Future Oncol (2012) 0.91
Polyomavirus-infected dendritic cells induce antiviral CD8(+) T lymphocytes. J Virol (2000) 0.86
Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice. Infect Immun (2001) 0.84
T cell vaccinology: exploring the known unknowns. Vaccine (2012) 0.83
Role of circulating lymphocytes in patients with sepsis. Biomed Res Int (2014) 0.80
Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury. Shock (2009) 0.78
Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice. Clin Exp Immunol (2012) 0.77
Dendritic cells and the control of immunity. Nature (1998) 56.54
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science (1990) 12.13
A cell culture model for T lymphocyte clonal anergy. Science (1990) 9.86
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med (1996) 9.31
The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med (1983) 7.55
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity (1994) 7.22
Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology (1962) 6.24
The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity (1994) 6.18
INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE. Proc R Soc Lond B Biol Sci (1964) 5.68
Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med (1996) 5.32
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29
Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science (1998) 5.19
Mice deficient for the CD40 ligand. Immunity (1994) 4.45
Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science (1971) 4.13
B cells turn off virgin but not memory T cells. Science (1992) 4.12
Cellular mechanisms of immunologic tolerance. Annu Rev Immunol (1983) 4.07
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity (1997) 4.05
The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med (1994) 3.66
Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med (1992) 3.52
Humoral immune responses in CD40 ligand-deficient mice. J Exp Med (1994) 3.32
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J Immunol (1997) 2.33
Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol (1998) 2.01
CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci U S A (1994) 1.96
A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J Exp Med (1998) 1.84
The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today (1996) 1.84
A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today (1996) 1.67
Current status of immunological adjuvants. Annu Rev Immunol (1986) 1.65
In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med (1993) 1.57
Microbial induction of co-stimulatory activity for CD4 T-cell growth. Int Immunol (1991) 1.54
Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat Med (1997) 1.35
Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc Natl Acad Sci U S A (1998) 1.29
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol (1990) 1.29
Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immunol (1997) 1.05
Bacterial lipopolysaccharide (endotoxin) interferes with the induction of tolerance and primes thymus-derived lymphocytes. J Immunol (1981) 0.97
The mass and oxygen capacity of the blood in man. J Physiol (1900) 10.55
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med (1994) 8.97
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature (1997) 8.59
RANK is essential for osteoclast and lymph node development. Genes Dev (1999) 5.85
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66
Studies with DNA-cellulose chromatography. I. DNA-binding proteins from Escherichia coli. Cold Spring Harb Symp Quant Biol (1968) 5.60
Crystal structure of core streptavidin determined from multiwavelength anomalous diffraction of synchrotron radiation. Proc Natl Acad Sci U S A (1989) 5.57
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood (2000) 5.06
Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med (1999) 4.92
Molecular and biological characterization of a murine ligand for CD40. Nature (1992) 4.83
The Absorption of Oxygen by the Lungs. J Physiol (1897) 4.50
A prospective study of advance directives for life-sustaining care. N Engl J Med (1991) 3.72
Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol (1997) 3.56
The Oxygen Tension of Arterial Blood. J Physiol (1896) 3.40
oskar mRNA is localized to the posterior pole of the Drosophila oocyte. Cell (1991) 3.39
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
Humoral immune responses in CD40 ligand-deficient mice. J Exp Med (1994) 3.32
Controlled trial of homoeopathic treatment of osteoarthritis. Lancet (1983) 3.30
A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature (1995) 3.30
Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol (1993) 3.29
The pathological effects due to increase of oxygen tension in the air breathed. J Physiol (1899) 3.28
Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4. J Virol (1987) 3.24
Hepatitis B infection in physicians. Results of a nationwide seroepidemiologic survey. JAMA (1978) 3.24
Fas transduces activation signals in normal human T lymphocytes. J Exp Med (1993) 3.04
Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med (1994) 2.90
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med (1992) 2.86
Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution. J Mol Biol (1987) 2.79
Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med (1999) 2.76
Teaching with audiovisual recordings of consultations. J R Coll Gen Pract (1980) 2.60
Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology (1982) 2.60
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood (2000) 2.45
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
Paracentric inversions in humans: a review of 446 paracentric inversions with presentation of 120 new cases. Am J Med Genet (1995) 2.39
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
Spirochetes in the aqueous humor in seronegative ocular syphilis. Persistence after penicillin therapy. Arch Ophthalmol (1967) 2.30
Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr (1990) 2.26
Cystic fibrosis: scoring system with thin-section CT. Radiology (1991) 2.21
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell (1992) 2.19
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest (1997) 2.18
Motility in Pseudomonas fluorescens with special reference to survival advantage and negative chemotaxis. Life Sci (1968) 2.17
ON A CASE OF SEPTICAEMIA TREATED BY INTRAVENOUS INJECTION OF EUSOL. Br Med J (1915) 2.16
Spontaneous regression of primary malignant melanomas with regional metastases. Cancer (1965) 2.15
Structure of a dehydratase-isomerase from the bacterial pathway for biosynthesis of unsaturated fatty acids: two catalytic activities in one active site. Structure (1996) 2.14
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet (1993) 2.12
CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity (1996) 2.11
The crystal structure of GMP synthetase reveals a novel catalytic triad and is a structural paradigm for two enzyme families. Nat Struct Biol (1996) 2.11
A new modification of the Krajian silver stain for Treponema pallidum. Br J Vener Dis (1969) 2.09
Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med (2000) 2.09
Using the Internet for psychological research: personality testing on the World Wide Web. Br J Psychol (1999) 2.06
Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol (1987) 2.05
Direct phase determination based on anomalous scattering. Methods Enzymol (1985) 2.02
Hereditary aspects of malignant melanoma. JAMA (1967) 1.98
Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol (1988) 1.97
Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology (1988) 1.97
Incidence of reactive VDRL tests in the normal rabbit. Br J Vener Dis (1967) 1.94
T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens. Clin Exp Immunol (1976) 1.91
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med (1999) 1.88
Experimental Observations ON THE ANTISEPTIC ACTION OF HYPOCHLOROUS ACID AND ITS APPLICATION TO WOUND TREATMENT. Br Med J (1915) 1.87
B- and T-lymphocyte markers on transformed lymphocytes from mitogen-stimulated cultures of normal and CLL lymphocytes and on tonsil blasts. Clin Exp Immunol (1974) 1.86
Multiple RNA regulatory elements mediate distinct steps in localization of oskar mRNA. Development (1993) 1.86
cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature (1994) 1.85
Optic nerve sheath decompression for relief of chronic monocular choked disc. Am J Ophthalmol (1969) 1.84
Microbiology of the frankfurter process: salmonella and natural aerobic flora. Appl Microbiol (1974) 1.83
Muscle fibre type populations of human leg muscles. Histochem J (1975) 1.83
Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol (1993) 1.81
Impaired expansion of mouse B cell progenitors lacking Btk. Immunity (1995) 1.79
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration (2011) 1.78
Characterisation of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin. Lancet (1973) 1.78
Aspirin and the stomach. Ann Intern Med (1986) 1.77
In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood (2000) 1.76
RNA regulatory element BLE1 directs the early steps of bicoid mRNA localization. Development (1993) 1.76
Whence pseudotumor cerebri? J Clin Neuroophthalmol (1985) 1.76
Recovery of Treponema pallidum from aqueous humor removed at cataract surgery in man by passive transfer to rabbit testis. Am J Ophthalmol (1968) 1.76
A mutant herpesvirus protein leads to a block in nuclear localization of other viral proteins. Mol Cell Biol (1986) 1.75
Immunological reason for chronic ill health after infectious mononucleosis. Br Med J (Clin Res Ed) (1983) 1.74
Locally critical quantum phase transitions in strongly correlated metals. Nature (2001) 1.74
Studies on negative chemotaxis and the survival value of motility in Pseudomonas fluorescens. J Gen Microbiol (1969) 1.71
Mouse thymus dendritic cells: kinetics of development and changes in surface markers during maturation. Eur J Immunol (1995) 1.71
Non-tumor causes of the Foster Kennedy syndrome. J Neurosurg (1967) 1.71
Coupled formation of an amidotransferase interdomain ammonia channel and a phosphoribosyltransferase active site. Biochemistry (1997) 1.70
Direct evidence for thymic function in adult humans. J Exp Med (1999) 1.70
The current status of treponema cuniculi. Review of the literature. Br J Vener Dis (1967) 1.69
Painful ophthalmoplegia. The Tolosa-Hunt syndrome. Am J Ophthalmol (1966) 1.68
Enzymes utilizing glutamine as an amide donor. Adv Enzymol Relat Areas Mol Biol (1998) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Modulating the immune response with dendritic cells and their growth factors. Trends Immunol (2001) 1.66
Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces. J Clin Virol (2003) 1.65
Mechanisms of neurulation: traditional viewpoint and recent advances. Development (1990) 1.64
Crystallographic structure analysis of lamprey hemoglobin from anomalous dispersion of synchrotron radiation. Proteins (1988) 1.64
CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions. J Exp Med (1996) 1.62
Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation. Antimicrob Agents Chemother (1997) 1.60
The fluorescent antibody tissue stain for Treponema pallidum in the eye. Am J Ophthalmol (1967) 1.59